Gold entered a bull market around mid-2023, with prices crossing the $2,000 per ounce threshold and enjoying strong momentum ever since. With gold pushing past…
View More Gold Prices Could Surge to $5,000 — Should You Buy Wheaton Precious Metals Stock Now? | The Motley FoolCategory: Investing
What’s the New 2026 Estate Tax Exemption Amount?
The federal estate tax exemption increased again for 2026. Yet, the higher, IRS-inflation-adjusted number may not come as a surprise to most who have been…
View More What’s the New 2026 Estate Tax Exemption Amount?A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years | The Motley Fool
It’s the best time in a while to scoop up shares of this stock from the discount bin. Over the past decade, pharmaceutical maker Pfizer…
View More A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years | The Motley FoolIs Archer Aviation Stock a Buy? | The Motley Fool
Electric helicopters are a huge long-term opportunity. But timing is everything for investors. With shares up by an impressive 307% over the last 12 months,…
View More Is Archer Aviation Stock a Buy? | The Motley FoolThe Economy on a Knife’s Edge
To help you understand what is going on in new technologies and the economy, our highly experienced Kiplinger Letter team will keep you abreast of…
View More The Economy on a Knife’s EdgeHave $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now | The Motley Fool
These stocks’ low valuations may come as a surprise to investors. One great thing about stock market investing is that there are always opportunities to…
View More Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now | The Motley FoolFinancial Fact vs Fiction: The Truth About Social Security Entitlement (and Reverse Mortgages’ Bad Rap)
Editor’s note: This is part four of a four-part series exploring financial fact vs fiction. Each article examines five of the top 20 most common…
View More Financial Fact vs Fiction: The Truth About Social Security Entitlement (and Reverse Mortgages’ Bad Rap)New to Growth Stocks? Here’s 1 Every Investor Should Have on Their Radar. | The Motley Fool
CRISPR Therapeutics is a promising mid-cap biotech stock with an approved product in its portfolio. Investing in modestly sized growth stocks can lead to significant…
View More New to Growth Stocks? Here’s 1 Every Investor Should Have on Their Radar. | The Motley FoolI More Than Doubled My Stake in This Can’t-Miss Monthly Dividend Stock With a Supercharged (and Sustainable) 14% Yield | The Motley Fool
This under-the-radar business development company might be the safest double-digit-yielding stock on the planet. With thousands of publicly traded companies and exchange-traded funds (ETFs) to…
View More I More Than Doubled My Stake in This Can’t-Miss Monthly Dividend Stock With a Supercharged (and Sustainable) 14% Yield | The Motley Fool3 Big Mistakes for Artificial Intelligence (AI) Growth Stock Investors to Avoid in 2026 | The Motley Fool
These investing best practices are especially important as tensions heat up between the U.S. and China. The Nasdaq Composite‘s brutal 3.6% sell-off on Oct. 10 was…
View More 3 Big Mistakes for Artificial Intelligence (AI) Growth Stock Investors to Avoid in 2026 | The Motley Fool